Skip to main content

Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 1, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Nov. 1, 2024 -- Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research letter published online Oct. 31 in JAMA Network Open.

Monique M. Hedderson, Ph.D., from Kaiser Permanente in Pleasanton, California, and colleagues examined the associations of frequency and trajectories of VMS with incident T2D over the MT in the Study of Women's Health Across the Nation. A total of 2,761 premenopausal or early perimenopausal women were assessed at up to 13 approximately annual follow-up visits.

At baseline, 28, 10, and 62 percent of women reported VMS on one to five days per two-week period, VMS on six or more days per week, and no VMS, respectively. Overall, 12.2 percent developed diabetes during follow-up. The researchers observed an association for more frequent time-varying VMS with an increased risk for incident diabetes (hazard ratios, 1.45 and 1.30 for frequent and infrequent VMS, respectively, versus no VMS), after adjustment for covariates. There were four trajectories of VMS: consistently low probability of VMS (26 percent), persistently high probability of VMS (31 percent), early onset-initial high probability that decreased over time (25 percent), and late onset-initial low probability that increased over time (19 percent); 0.2 percent of patients had unknown trajectory. Compared with women with consistently low VMS, those with persistently high VMS had an increased risk for diabetes (hazard ratio, 1.50).

"Women with frequent and/or persistent VMS over the MT may represent a high-risk group to target for diabetes prevention," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide

FRIDAY, Nov. 22, 2024 -- More than half of all U.S. adults are eligible for semaglutide therapy, according to a research letter published online Nov. 18 in JAMA Cardiology to...

AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes

WEDNESDAY, Nov. 20, 2024 -- For patients with type 2 diabetes and elevated systolic blood pressure, an intensive-treatment strategy is better than a standard-treatment strategy...

Metformin Use Tied to Lower Rate of Asthma Attacks

MONDAY, Nov. 18, 2024 -- Metformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in JAMA...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.